
Over 15 months, Rob Croker delivered robust data engineering, backend, and frontend enhancements for the bennettoxford/openprescribing repository. He modernized data models, expanded clinical datasets, and improved analytics reliability by implementing SQL-based metrics, JSON configuration updates, and automated CI/CD pipelines. Rob’s work included refining opioid and inhaler measures, optimizing database queries, and enhancing API documentation for multi-drug queries. He improved UI maintainability with Django templating and HTML updates, while also ensuring data accuracy through rigorous bug fixes and code refactoring. Using Python, SQL, and JavaScript, Rob consistently prioritized maintainability, data quality, and user-focused reporting across the project’s evolving requirements.
February 2026 monthly summary for bennettoxford/openprescribing. Delivered substantial data/config updates to Omnibus measures, aligned datasets with late-2025 formats, enhanced query capabilities, and improved UI/reporting. Also completed targeted code quality work to tighten wording, fix typos, and standardize formatting, contributing to maintainability and faster future changes.
February 2026 monthly summary for bennettoxford/openprescribing. Delivered substantial data/config updates to Omnibus measures, aligned datasets with late-2025 formats, enhanced query capabilities, and improved UI/reporting. Also completed targeted code quality work to tighten wording, fix typos, and standardize formatting, contributing to maintainability and faster future changes.
2026-01 Monthly Summary: In bennettoxford/openprescribing, focused on improving maintainability and release reliability through two main deliveries: (1) UI/template cleanliness by refining dmd_obj.html, (2) automated release workflow via CI/CD setup. No critical bugs addressed this month; stability remained solid across the repository. Business impact: reduced UI risk, cleaner templates reducing future technical debt, and faster, more reliable releases via automated checks and deployment.
2026-01 Monthly Summary: In bennettoxford/openprescribing, focused on improving maintainability and release reliability through two main deliveries: (1) UI/template cleanliness by refining dmd_obj.html, (2) automated release workflow via CI/CD setup. No critical bugs addressed this month; stability remained solid across the repository. Business impact: reduced UI risk, cleaner templates reducing future technical debt, and faster, more reliable releases via automated checks and deployment.
December 2025 performance summary for bennettoxford/openprescribing: Focused on delivering business-value opioid measures, data accuracy, frontend improvements, and code quality. Key work spanned data definitions, calculations, SQL reliability, and UI maintenance, with testing alignment and configuration updates. These changes enhance data accuracy, enable incentives, improve reliability, and reduce technical debt.
December 2025 performance summary for bennettoxford/openprescribing: Focused on delivering business-value opioid measures, data accuracy, frontend improvements, and code quality. Key work spanned data definitions, calculations, SQL reliability, and UI maintenance, with testing alignment and configuration updates. These changes enhance data accuracy, enable incentives, improve reliability, and reduce technical debt.
November 2025 monthly summary for bennettoxford/openprescribing: Released policy-aligned opioid prescribing measure updates and corrected concession data to enhance data accuracy, safety, and decision support. Delivered changes via commits to JSON config files and a CSV fix, improving data quality for clinicians and analysts.
November 2025 monthly summary for bennettoxford/openprescribing: Released policy-aligned opioid prescribing measure updates and corrected concession data to enhance data accuracy, safety, and decision support. Delivered changes via commits to JSON config files and a CSV fix, improving data quality for clinicians and analysts.
October 2025 monthly summary for bennettoxford/openprescribing: Implemented essential CI/CD and release-facing improvements, clarified project changes for users, and fixed a critical readability issue to ensure stable operation. These changes enhance release velocity, transparency, and code quality across the repository.
October 2025 monthly summary for bennettoxford/openprescribing: Implemented essential CI/CD and release-facing improvements, clarified project changes for users, and fixed a critical readability issue to ensure stable operation. These changes enhance release velocity, transparency, and code quality across the repository.
September 2025 (2025-09) monthly summary for bennettoxford/openprescribing. Delivered data-model and UI enhancements, expanded dataset coverage, and implemented essential bug fixes to improve data quality and analytics reliability. Focused on delivering business value through more complete datasets, accurate dashboards, and scalable data definitions. Key features delivered included a new Presentation Ingredient Count View, VMP inclusion, Environmental Inhalers measures, and dataset enrichments across detemir, saba, vitamind, aware_antibiotics, and manually_added_concessions. UI improvements included adding a CSS link and asset uploads. Major bugs fixed targeted data quality and SQL reliability to ensure robust dashboards.
September 2025 (2025-09) monthly summary for bennettoxford/openprescribing. Delivered data-model and UI enhancements, expanded dataset coverage, and implemented essential bug fixes to improve data quality and analytics reliability. Focused on delivering business value through more complete datasets, accurate dashboards, and scalable data definitions. Key features delivered included a new Presentation Ingredient Count View, VMP inclusion, Environmental Inhalers measures, and dataset enrichments across detemir, saba, vitamind, aware_antibiotics, and manually_added_concessions. UI improvements included adding a CSS link and asset uploads. Major bugs fixed targeted data quality and SQL reliability to ensure robust dashboards.
August 2025 monthly summary for bennettoxford/openprescribing: Delivered a comprehensive data refresh and feature enhancements that improve data freshness, pricing accuracy, and product capabilities. Implemented a dataset and data model refresh across statin intensity, antibiotic awareness, NHS BGTS, concessions, dapagliflozin data, and saba dependencies. Introduced an inhaler quantity correction SQL view with accompanying cost-based tests to ensure pricing accuracy. Integrated a WIM component as part of product enhancements. Performed targeted code quality improvements to improve data integrity and readability, including fixes to typos and URL references. These changes support more reliable dashboards, accurate cost calculations, and faster iteration cycles for data-driven decision making.
August 2025 monthly summary for bennettoxford/openprescribing: Delivered a comprehensive data refresh and feature enhancements that improve data freshness, pricing accuracy, and product capabilities. Implemented a dataset and data model refresh across statin intensity, antibiotic awareness, NHS BGTS, concessions, dapagliflozin data, and saba dependencies. Introduced an inhaler quantity correction SQL view with accompanying cost-based tests to ensure pricing accuracy. Integrated a WIM component as part of product enhancements. Performed targeted code quality improvements to improve data integrity and readability, including fixes to typos and URL references. These changes support more reliable dashboards, accurate cost calculations, and faster iteration cycles for data-driven decision making.
July 2025 monthly summary for bennettoxford/openprescribing: deprecation of the Long Term Trends (LTT) feature in the UI and a comprehensive cleanup of FAQ and data-source references, coupled with a clarified National Trends description to reflect data within the last 5 years. These changes reduce user confusion, align with the updated data strategy, and simplify ongoing maintenance by removing outdated UI elements and content. The work demonstrates governance over data presentation, improved documentation accuracy, and a user-centric, low-friction interface.
July 2025 monthly summary for bennettoxford/openprescribing: deprecation of the Long Term Trends (LTT) feature in the UI and a comprehensive cleanup of FAQ and data-source references, coupled with a clarified National Trends description to reflect data within the last 5 years. These changes reduce user confusion, align with the updated data strategy, and simplify ongoing maintenance by removing outdated UI elements and content. The work demonstrates governance over data presentation, improved documentation accuracy, and a user-centric, low-friction interface.
May 2025 monthly summary for bennettoxford/openprescribing focusing on business value and technical accomplishments. Delivered feature enhancements to improve data accessibility and readability, updated datasets, and improved navigational UX. These changes enhance clinician access to hospital data and drug tariff information, improve data maintainability, and reduce user churn by preventing navigational drop-offs.
May 2025 monthly summary for bennettoxford/openprescribing focusing on business value and technical accomplishments. Delivered feature enhancements to improve data accessibility and readability, updated datasets, and improved navigational UX. These changes enhance clinician access to hospital data and drug tariff information, improve data maintainability, and reduce user churn by preventing navigational drop-offs.
April 2025 — BennettoOxford/OpenPrescribing: API documentation enhancements focused on multi-drug spending queries and readability. Implemented examples for querying spending data for multiple drugs using comma-separated BNF codes, and performed formatting and typographical fixes to improve readability and the accuracy of spending, quantity, and item calculations described in the docs. No code defects fixed this month; primary value added is clearer guidance for users and reduced potential for misinterpretation.
April 2025 — BennettoOxford/OpenPrescribing: API documentation enhancements focused on multi-drug spending queries and readability. Implemented examples for querying spending data for multiple drugs using comma-separated BNF codes, and performed formatting and typographical fixes to improve readability and the accuracy of spending, quantity, and item calculations described in the docs. No code defects fixed this month; primary value added is clearer guidance for users and reduced potential for misinterpretation.
Monthly summary for 2025-03 for bennettoxford/openprescribing: Delivered Blood glucose testing strips data enrichment and mapping to improve price-per-unit analytics. Implemented inclusion of specific drug codes and alternate formulations, with a synthetic BNF code/name to handle missing/non-standard codes and ensure consistent display. Code changes included updates to swaps_bigquery.sql and addition of a fake BGTS code (commits 8d84f943d0689190e2f443d24dd46ebb86c66917; 5fa49b1edd6131d6f51985a54431c87cf67c6b41). This work enhances data quality, reliability of cost metrics, and supports scalable handling of non-standard codes for procurement analytics.
Monthly summary for 2025-03 for bennettoxford/openprescribing: Delivered Blood glucose testing strips data enrichment and mapping to improve price-per-unit analytics. Implemented inclusion of specific drug codes and alternate formulations, with a synthetic BNF code/name to handle missing/non-standard codes and ensure consistent display. Code changes included updates to swaps_bigquery.sql and addition of a fake BGTS code (commits 8d84f943d0689190e2f443d24dd46ebb86c66917; 5fa49b1edd6131d6f51985a54431c87cf67c6b41). This work enhances data quality, reliability of cost metrics, and supports scalable handling of non-standard codes for procurement analytics.
February 2025 delivered data-layer enhancements in bennettoxford/openprescribing focusing on accuracy, pricing, and insight quality. Implemented drug matching enhancements with inhaler device handling and preservative-free flags, updated pricing configuration for LP/CROX pricing, and refreshed prescribing data window for Improvement Radar to December 2024. No major customer-facing bugs were fixed this month; core work consisted of data and configuration improvements that enable safer prescribing and more reliable insights. Overall impact includes improved matching accuracy, up-to-date pricing data, and more actionable analytics for product and clinical decisions.
February 2025 delivered data-layer enhancements in bennettoxford/openprescribing focusing on accuracy, pricing, and insight quality. Implemented drug matching enhancements with inhaler device handling and preservative-free flags, updated pricing configuration for LP/CROX pricing, and refreshed prescribing data window for Improvement Radar to December 2024. No major customer-facing bugs were fixed this month; core work consisted of data and configuration improvements that enable safer prescribing and more reliable insights. Overall impact includes improved matching accuracy, up-to-date pricing data, and more actionable analytics for product and clinical decisions.
January 2025: Delivered substantial BDZ/ADQ data model modernization and dataset enhancements for OpenPrescribing. Focused on data/file-structure updates, migration to view-based BDZ/ADQ metrics, expanded data coverage, UI alignment, and governance improvements to improve data quality, reporting speed, and business value.
January 2025: Delivered substantial BDZ/ADQ data model modernization and dataset enhancements for OpenPrescribing. Focused on data/file-structure updates, migration to view-based BDZ/ADQ metrics, expanded data coverage, UI alignment, and governance improvements to improve data quality, reporting speed, and business value.
Month: 2024-12 | Concise monthly summary for bennettoxford/openprescribing focusing on delivering NICE-guided data updates, reliability improvements, and user-facing link fixes. Emphasizes business value and technical achievements with concrete deliveries and measurable impact.
Month: 2024-12 | Concise monthly summary for bennettoxford/openprescribing focusing on delivering NICE-guided data updates, reliability improvements, and user-facing link fixes. Emphasizes business value and technical achievements with concrete deliveries and measurable impact.
November 2024 monthly summary for bennettoxford/openprescribing: Focused on improving the How-to-use page by enhancing webinar resources and YouTube embeds to boost user engagement and resource discoverability. Implemented embedded webinar videos, made webinar sections visible by uncommenting content, and cleaned YouTube embed URLs for better compatibility and loading performance. Three dedicated commits under the how-to-use.html page reflect a cohesive update effort. Major bugs fixed: none recorded in this dataset.
November 2024 monthly summary for bennettoxford/openprescribing: Focused on improving the How-to-use page by enhancing webinar resources and YouTube embeds to boost user engagement and resource discoverability. Implemented embedded webinar videos, made webinar sections visible by uncommenting content, and cleaned YouTube embed URLs for better compatibility and loading performance. Three dedicated commits under the how-to-use.html page reflect a cohesive update effort. Major bugs fixed: none recorded in this dataset.

Overview of all repositories you've contributed to across your timeline